Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial.

@article{Okusaka2009TransarterialCA,
  title={Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial.},
  author={Takuji Okusaka and Hiroshi Kasugai and Yasukazu Shioyama and Katsuaki Tanaka and Masatoshi Kudo and Hiromitsu Saisho and Yukio Osaki and Michio Sata and Shigetoshi Fujiyama and Takashi Kumada and Keiko Sato and Seiichiro Yamamoto and Shiro Hinotsu and Tosiya Sato},
  journal={Journal of hepatology},
  year={2009},
  volume={51 6},
  pages={1030-6}
}
BACKGROUND/AIMS Transcatheter arterial chemoembolization (TACE) is a combination of transarterial infusion chemotherapy (TAI) and embolization, and has been widely used to treat patients with hepatocellular carcinoma (HCC). However, since the impact of adding embolization on the survival of patients treated with TAI had never been evaluated in a phase III study, we conducted a multi-center, open-label trial comparing TACE and TAI to assess the effect of adding embolization on survival… CONTINUE READING
35 Citations
23 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 35 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 23 references

Similar Papers

Loading similar papers…